The following table presents revenue by category:


	Three Months Ended June 30,
	2023					2022
	Amount		% of Revenue			Amount		% of Revenue
	(in thousands, except percentages)
Point in Time
PGS	$	31,759		52	%	$	39,691		61	%
Telehealth		8,285		14	%		9,361		15	%
Consumer services		40,044		66	%		49,052		76	%
Research services		2,353		3	%		—		0	%
Total	$	42,397		69	%	$	49,052		76	%

Over Time
PGS	$	5,270		9	%	$	4,484		7	%
Telehealth		2,238		4	%		2,523		4	%
Consumer services		7,508		13	%		7,007		11	%
Research services		10,959		18	%		8,454		13	%
Total	$	18,467		31	%	$	15,461		24	%

Revenue by Category
PGS	$	37,029		61	%	$	44,175		68	%
Telehealth		10,523		18	%		11,884		19	%
Consumer services		47,552		79	%		56,059		87	%
Research services		13,312		21	%		8,454		13	%
Total	$	60,864		100	%	$	64,513		100	%

The following table summarizes revenue by region based on the shipping address of customers or the location where the services are delivered:


	Three Months Ended June 30,
	2023					2022
	Amount		% of Revenue			Amount		% of Revenue
	(in thousands, except percentages)
United States	$	43,326		71	%	$	48,108		75	%
United Kingdom		14,355		24	%		11,975		19	%
Canada		2,170		3	%		3,039		4	%
Other regions		1,013		2	%		1,391		2	%
Total	$	60,864		100	%	$	64,513		100	%

The Company sells through multiple channels, including direct-to-consumer via the Company’s website and through online retailers. If the customer does not return the Kit for processing, services cannot be completed by the Company, potentially resulting in unexercised rights (“breakage”) revenue. The Company recognized breakage revenue from unreturned Kits of $4.6 million and $5.0 million for the three months ended June 30, 2023 and 2022, respectively.

Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts associated with contractual rights related to consideration for performance obligations and are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. The amount of contract assets was immaterial as of June 30, 2023 and March 31, 2023.

Contract liabilities consist of deferred revenue. As of June 30, 2023 and March 31, 2023, deferred revenue for consumer services was $45.9 million and $48.6 million, respectively. Of the $48.6 million of deferred revenue for consumer services as of March 31, 2023, the Company recognized $22.5 million as revenue during the three months ended June 30, 2023.

As of June 30, 2023 and March 31, 2023, deferred revenue for research services was $2.2 million and $14.0 million, respectively, which included related party deferred revenue amounts of $1.1 million and $11.8 million, respectively. Of the $14.0 million of deferred revenue for research services as of March 31, 2023, the Company recognized $12.4 million as revenue during the three months ended June 30, 2023, which included related party revenue amounts of $10.7 million.

The transaction price allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that are expected to be billed and recognized as revenue in future periods. The Company has utilized the practical expedient available under Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”) to not disclose the value of unsatisfied performance obligations for PGS and telehealth as those contracts have an expected length of one year or less. As of June 30, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations for research services was $3.1 million. The Company expects to recognize revenue of approximately 81% of this amount over the next 12 months and the remainder thereafter. During the three months ended June 30, 2023 and 2022, the Company did not recognize any revenue for performance obligations satisfied in prior periods.